CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to CLDX

Anti-CD40 Agonist Monoclonal Antibody CDX-1140

Phase 2
Celldex Therapeutics, Inc. (CLDX)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Mar '27
CLDXPhase 2

Anti-CD40 Agonist Monoclonal Antibody CDX-1140 Phase 2 Est. Readout

Anti-CD40 Agonist Monoclonal Antibody CDX-1140
Mar 2027~
CT.gov
00%
Competitive Landscape

0 competitors in Ovarian Clear Cell Adenocarcinoma

View Full Landscape
Drug Information

Target Indication

Ovarian Clear Cell Adenocarcinoma

Clinical Trial

NCT05231122

Last updated: 8/15/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.